Medicare Enrolled
Dr. Romanth Waghmarae
Anesthesiology · Hamburg, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Waghmarae from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Waghmarae?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Waghmarae
Dr. Romanth Waghmarae is an anesthesiology specialist in Hamburg, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Waghmarae performed 506 Medicare services across 315 unique beneficiaries.
Between the years covered by Open Payments, Dr. Waghmarae received a total of $324,625 from 89 pharmaceutical and/or device companies across 1679 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in anesthesiology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Waghmarae is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 11% volume in NY
$324,625 industry payments
Medicare Practice Summary
Medicare Utilization ↗506
Medicare services
Top 11% in NY for anesthesiology
315
Unique beneficiaries
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~27 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
246 | $58 | $213 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
77 | $87 | $314 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
32 | $54 | $156 |
| Peripheral nerve neurostimulator electrode insertion A procedure to place an electrode through the skin into a peripheral nerve. This electrode is part of a neurostimulator system used to deliver electrical impulses. |
22 | $169 | $3,521 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
22 | $98 | $478 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
21 | $0 | $0 |
| Electronic analysis of implanted neurostimulator with complex programming This procedure involves the electronic evaluation of an implanted neurostimulator generator. It includes complex programming of spinal cord or peripheral nerve stimulators. |
20 | $29 | $171 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
19 | $70 | $715 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
19 | $174 | $596 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
14 | $100 | $824 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
14 | $57 | $414 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$324,625
Total received (2018-2024)
Avg $46,375/year across 7 years
Top 0% in NY for anesthesiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
89
Companies
1,679
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$281,013 (86.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$43,612 (13.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$11,558
2023
$21,105
2022
$28,221
2021
$22,779
2020
$19,479
2019
$43,586
2018
$177,897
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
SCILEX PHARMACEUTICALS INC.
$4,218
Saluda Medical Americas, Inc.
$2,145
Curonix LLC
$1,279
Spinal Simplicity, LLC
$1,177
PROTEGA PHARMACEUTIALS INC
$965
SPR Therapeutics, Inc
$467
Nevro Corp.
$467
MML US, Inc.
$147
Collegium Pharmaceutical, Inc.
$136
VERTEX PHARMACEUTICALS INCORPORATED
$131
Boston Scientific Corporation
$90
Vertos Medical, Inc.
$89
Averitas Pharma Inc.
$69
ABBVIE INC.
$40
Medtronic, Inc.
$39
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$36
SI-BONE, INC.
$32
Lundbeck LLC
$16
Alkermes, Inc.
$15
Top 3 companies account for 66.1% of 2024 payments
All-time payments by company (2018-2024) ›
BOSTON SCIENTIFIC CORPORATION
$92,066
Daiichi Sankyo Inc.
$77,414
Boston Scientific Corporation
$37,412
SCILEX PHARMACEUTICALS INC.
$18,856
GRT US Holding, Inc.
$17,941
Medtronic, Inc.
$15,094
Collegium Pharmaceutical, Inc.
$12,452
Nevro Corp.
$8,992
Scilex Pharmaceuticals Inc.
$7,179
AstraZeneca Pharmaceuticals LP
$4,601
Pernix Therapeutics Holdings, Inc.
$3,099
Saluda Medical Americas, Inc.
$2,812
Medtronic Vascular, Inc.
$2,058
Vertiflex, Inc.
$1,833
Amgen Inc.
$1,818
Curonix LLC
$1,744
Medtronic USA, Inc.
$1,406
SPINEFRONTIER, INC.
$1,243
SPR Therapeutics, Inc
$1,223
Spinal Simplicity, LLC
$1,177
SI-BONE, INC.
$1,137
PROTEGA PHARMACEUTIALS INC
$965
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$917
Abbott Laboratories
$798
Teva Pharmaceuticals USA, Inc.
$727
Vertos Medical, Inc.
$540
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$514
AbbVie Inc.
$513
Biohaven Pharmaceuticals, Inc.
$420
Allergan, Inc.
$412
Relievant Medsystems, Inc.
$394
Sentynl Therapeutics, Inc.
$345
Indivior Inc.
$342
US WorldMeds, LLC
$328
ARBOR PHARMACEUTICALS, INC.
$308
ABBVIE INC.
$300
PFIZER INC.
$300
Biogen, Inc.
$295
Mallinckrodt LLC
$249
Assertio Therapeutics, Inc.
$246
Almatica Pharma LLC
$238
Amneal Pharmaceuticals LLC
$225
Novartis Pharmaceuticals Corporation
$218
Horizon Therapeutics plc
$202
Orexo US, Inc.
$190
Biohaven Pharmaceutical Holding Company Ltd.
$178
Zyla Life Sciences
$176
Egalet US Inc
$160
Zyla Life Sciences, Inc.
$151
MML US, Inc.
$147
BioDelivery Sciences International, Inc.
$140
Horizon Pharma plc
$140
Alnylam Pharmaceuticals Inc.
$137
VERTEX PHARMACEUTICALS INCORPORATED
$131
BAUDAX BIO INC.
$129
Vanda Pharmaceuticals Inc.
$125
EAGLE PHARMACEUTICALS, INC.
$125
Alfasigma USA, Inc.
$105
SI-BONE, Inc.
$97
UPSHER-SMITH LABORATORIES LLC
$90
Averitas Pharma Inc.
$88
Upsher-Smith Laboratories LLC
$71
Takeda Pharmaceuticals U.S.A., Inc.
$65
Acorda Therapeutics, Inc
$62
Azurity Pharmaceuticals, Inc.
$60
Nalu Medical, Inc.
$58
USWM, LLC
$56
ASSERTIO THERAPEUTICS, Inc.
$53
MDD US Operations, LLC
$48
Kyowa Kirin, Inc.
$48
Vertical Pharmaceuticals, LLC
$40
RedHill Biopharma Inc.
$39
Smith+Nephew, Inc.
$36
Shionogi Inc
$33
Arbor Pharmaceuticals, Inc.
$33
Smith & Nephew, Inc.
$30
Janssen Pharmaceuticals, Inc
$29
Purdue Pharma L.P.
$27
GENZYME CORPORATION
$25
Zimmer Biomet Holdings, Inc.
$22
Pacira Pharmaceuticals Incorporated
$18
Promius Pharma LLC
$18
Merck Sharp & Dohme Corporation
$17
Lundbeck LLC
$16
Alkermes, Inc.
$15
TerSera Therapeutics LLC
$13
IBSA Pharma Inc.
$13
Banner Life Sciences, LLC
$12
Foundation Fusion Solutions, LLC
$9
Top 3 companies account for 63.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADAPTIVESTIM · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMVUTTRA · ANJESO · APOKYN · AUBAGIO · AUSTEDO · Aimovig · Amitiza · Axium INS DRG IPG · BAFIERTAM · BELBUCA · BELSOMRA · BOTOX · BUNAVAIL 2.1 mg 30-count box · BYFAVO · Belbuca · Cambia · ClosureFast · DUEXIS · ELYXYB - celecoxib · EMBEDA · Eprontia · Evoke · Evoke SCS · Exparel · GENERAL PAIN MANAGEMENT · GENERAL THERAPIES · GENERAL - PAIN MANAGEMENT · GENERAL - THERAPIES · GENERAL PAIN MANAGEMENT · GRALISE · Gel One · General - Pain Management · Gralise · HA MINUTEMAN G3-R · HETLIOZ · Horizant · IFUSE IMPLANT SYSTEM · INBRIJA · INFINION · INTELLIS · INTELLIS ADAPTIVESTIM · Infinion 16 · Inspan · Intracept · LIBERTY SI · LORZONE · LYRICA · LYVISPAH · Levorphanol · Levorphanol Tartrate · Licart · Lucemyra · Lucemyra/Lofexidine · METHYLPHENIDATE 72 · MOVANTIK · MYOBLOC · Morphabond ER · Movantik · NAPRELAN · NURTEC ODT · Nalu Neurostimulation System · Neuromodulation Dspsbls and Accs · Nourianz · NucyntaER · OCTRODE · ONPATTRO · Omnia · PENNSAID · PICO · PICO Single Use Negative Pressure Wound Therapy · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PRECISION · PROCLAIM · Prialt · Proclaim DRG IPG · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · Qutenza · RAYOS · RELEXXII · RELISTOR · RESTORE · ROXYBOND · RYTARY · ReActiv8 · SPECTRA · SPECTRA WAVEWRITER · SPECTRA WAVEWRITER (REFURBISHED) · SPRINT PNS System · SPRIX · SUBLOCADE · SUBOXONE SUBLINGUAL FILM · SUPERION · SYMPROIC · Senza · Senza II · Senza Spinal Cord Stimulation System · Spectra WaveWriter · Superion · Superion ISS · Superion Indirect Decompression System · Symproic · THERAPIES · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TYSABRI · UBRELVY · UPLIZNA · VANTA ADAPTIVESTIM · VIVITROL · VUMERITY · VYEPTI · WaveWriter Alpha Prime 16 · XADAGO · XTAMPZA · XTAMPZAER · Xtampza ER · ZEMBRACE SYMTOUCH · ZIPSOR · ZOHYDRO ER · ZOMIG · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zipsor · Zubsolv · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (87%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in anesthesiology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for anesthesiology in NY.
Geographic Context
Anesthesiologists within 10 mi
204
Per 100K population
21.5
County median income
$71,175
Nearest hospital
MERCY HOSPITAL OF BUFFALO
9.2 mi
9.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Waghmarae is a clinical cardiology specialist, with above-average Medicare volume (top 11% in NY), with speaking/promotional industry engagement in the top 0% of NY peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Waghmarae experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Waghmarae performed 246 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Waghmarae receive payments from pharmaceutical companies?
Yes. Dr. Waghmarae received a total of $324,625 from 89 companies across 1,679 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Waghmarae's costs compare to other anesthesiologists in Hamburg?
Dr. Waghmarae's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Waghmarae) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Anesthesiologists in Hamburg
Browse anesthesiologists in Hamburg ranked by procedure volume and transparency data.
Highest volume
Top Anesthesiologists in NY
Anesthesiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Anesthesiologists in NY
Which NY anesthesiologists receive the most from drug and device companies.
By company
BOSTON SCIENTIFIC CORPORATION Payments to Doctors
See all physicians who received payments from BOSTON SCIENTIFIC CORPORATION.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology